James A. Jarvis, Giuliana Fusco, Christopher M. Dobson, Fabrizio Chiti, Alfonso De Simone, Liming Ying, Michele Perni, Roberta Cascella, Michele Vendruscolo, Nunilo Cremades, Cristina Cecchi, Philip T. F. Williamson, Serene W. Chen, Parkinson's Disease Society (UK), Medical Research Council (UK), Wellcome Trust, Leverhulme Trust, British Heart Foundation, Biotechnology and Biological Sciences Research Council (UK), Agency for Science, Technology and Research A*STAR (Singapore), Ministerio de Economía y Competitividad (España), Regione Toscana, Università degli Studi di Firenze, University of Cambridge, Fusco, G., Chen, S. W., Williamson, P. T. F., Cascella, R., Perni, M., Jarvis, J. A., Cecchi, C., Vendruscolo, M., Chiti, F., Cremades, N., Ying, L., Dobson, C. M., De Simone, A., Biotechnology and Biological Sciences Research Council (BBSRC), Medical Research Council (MRC), Parkinson's UK, Fusco, Giuliana [0000-0002-3644-9809], Chen, Serene W [0000-0001-7084-5621], Williamson, Philip TF [0000-0002-0231-8640], Cascella, Roberta [0000-0001-9856-6843], Perni, Michele [0000-0001-7593-8376], Cecchi, Cristina [0000-0001-8387-7737], Chiti, Fabrizio [0000-0002-1330-1289], Cremades, Nunilo [0000-0002-9138-6687], Ying, Liming [0000-0001-9752-6292], Dobson, Christopher M [0000-0002-5445-680X], De Simone, Alfonso [0000-0001-8789-9546], and Apollo - University of Cambridge Repository
5 pags, 3 figs, Oligomeric species populated during the aggregation process of a-synuclein have been linked to neuronal impairment in Parkinson's disease and related neurodegenerative disorders. By using solution and solid-state nuclear magnetic resonance techniques in conjunction with other structural methods, we identified the fundamental characteristics that enable toxic a-synuclein oligomers to perturb biological membranes and disrupt cellular function; these include a highly lipophilic element that promotes strong membrane interactions and a structured region that inserts into lipid bilayers and disrupts their integrity. In support of these conclusions, mutations that target the region that promotes strong membrane interactions by a-synuclein oligomers suppressed their toxicity in neuroblastoma cells and primary cortical neurons., This research was supported by Parkinson's UK (G-1508 to G.F., M.V., C.M.D., and A.D.); the UK Medical Research Council (MR/N000676/1 to G.F., M.V. C.M.D., and A.D.); the Wellcome Trust (104933/2/14E to kD.): the Leverhulme Trust (RPG-2015-350 to A.D. and RPG-2015-345 to L.Y.); the British Heart Foundation (PG/14/93/31237 to A.D. and PG/11/81/29130 to L.Y.); the UK Biotechnology and Biological Sciences Research Council (BB/M023923/1 to A.D. and BB/G00594X/1 to L.Y.); the Agency of Science, Technology and Research of Singapore (to S.W.C.); the Ministry of Economy, Industry, and Competitiveness of Spain (MINECO RYC-2012-12068 and MINECO/FEDER EU BEU2015-64119-P to N.C.); the Regione Toscana (SUPREMAL to E.C., C.C., and R.C); the University of Florence (Eondi di Ateneo to E.C. and. C.C); and the Centre for Misfolding Diseases of the University of Cambridge. The data supporting the findings of this study are available within the article and supplementary materials.